ECSP21043895A - Derivados de oxopiridina sustituidos - Google Patents
Derivados de oxopiridina sustituidosInfo
- Publication number
- ECSP21043895A ECSP21043895A ECSENADI202143895A ECDI202143895A ECSP21043895A EC SP21043895 A ECSP21043895 A EC SP21043895A EC SENADI202143895 A ECSENADI202143895 A EC SENADI202143895A EC DI202143895 A ECDI202143895 A EC DI202143895A EC SP21043895 A ECSP21043895 A EC SP21043895A
- Authority
- EC
- Ecuador
- Prior art keywords
- substitute
- oxopyridine derivatives
- derivatives
- thromboembolic
- oxopyridine
- Prior art date
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 230000009424 thromboembolic effect Effects 0.000 abstract 2
- 230000001732 thrombotic effect Effects 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 208000019553 vascular disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2018122825 | 2018-12-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP21043895A true ECSP21043895A (es) | 2021-07-30 |
Family
ID=69143542
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSENADI202143895A ECSP21043895A (es) | 2018-12-21 | 2021-06-16 | Derivados de oxopiridina sustituidos |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP3898633A1 (fr) |
| JP (1) | JP2022514303A (fr) |
| KR (1) | KR20210106504A (fr) |
| CN (1) | CN113474348A (fr) |
| AR (1) | AR117435A1 (fr) |
| AU (1) | AU2019407909B2 (fr) |
| BR (1) | BR112021009435A2 (fr) |
| CA (1) | CA3124220A1 (fr) |
| CL (1) | CL2021001613A1 (fr) |
| CO (1) | CO2021007908A2 (fr) |
| CR (1) | CR20210342A (fr) |
| DO (1) | DOP2021000128A (fr) |
| EA (1) | EA202191764A1 (fr) |
| EC (1) | ECSP21043895A (fr) |
| IL (1) | IL283990A (fr) |
| JO (1) | JOP20210161A1 (fr) |
| MA (1) | MA54521A (fr) |
| MX (1) | MX2021007508A (fr) |
| PE (1) | PE20211790A1 (fr) |
| SG (1) | SG11202104384PA (fr) |
| TW (1) | TW202039510A (fr) |
| WO (1) | WO2020127504A1 (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102807521B1 (ko) * | 2018-03-15 | 2025-05-16 | 바이엘 악티엔게젤샤프트 | 2종의 4-｛[(2s)-2-｛4-[5-클로로-2-(1h-1,2,3-트리아졸-1-일)페닐]-5-메톡시-2-옥소피리딘-1(2h)-일}부타노일]아미노}-2-플루오로벤즈아미드 유도체의 제조 방법 |
| CN114105881B (zh) | 2020-08-31 | 2024-01-26 | 沈阳海诺威医药科技有限公司 | 血小板聚集抑制剂及其制备方法和用途 |
| GEAP202316370A (en) | 2021-03-09 | 2023-11-27 | Bayer Ag | Pharmaceutical dosage forms comprising (4s)-24-chloro-4-ethyl-73-fluoro-35-methoxy-32,5-dioxo-14-(trifluoromethyl)-32h-6-aza-3(4,1)-pyridina-1(1)-[1,2,3] triazola-2(1,2),7(1)- dibenzenaheptaphane-74-carboxamide |
| WO2022189280A1 (fr) | 2021-03-09 | 2022-09-15 | Bayer Aktiengesellschaft | Solvates de (4s)-24-chloro-4-éthyl-73-fluoro-35-méthoxy-32,5-dioxo-14-(trifluoro-méthyl)-32 h-6- aza-3(4,1)-pyridina-1(1)-[1,2,3]triazola-2(1,2),7(1)-dibenzenaheptaphane-74-carboxamide |
| MX2023010614A (es) | 2021-03-09 | 2023-09-19 | Bayer Ag | Formas cristalinas de (4s)-24-cloro-4-etil-7?-fluoro-35-metoxi-3?, 5-dioxo-14-(trifluoro-metil)-3?h-6-aza-3(4,1)-piridina-1(1)-[1,2, 3]triazola-2(1,2),7(1)-dibencenaheptafano-74-carboxamida. |
| CN114560754A (zh) * | 2022-02-25 | 2022-05-31 | 滁州学院 | 一种烷基醇的制备方法 |
| EP4716732A1 (fr) * | 2023-04-28 | 2026-04-01 | Basf Se | Utilisation de 4-alcoxypentanoates d'alkyle comme arômes chimiques |
| CN116874469B (zh) * | 2023-09-06 | 2023-11-10 | 成都施贝康生物医药科技有限公司 | 一种氧代吡啶类化合物、中间体及其制备方法和用途 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0420722D0 (en) | 2004-09-17 | 2004-10-20 | Addex Pharmaceuticals Sa | Novel allosteric modulators |
| DE102006032824A1 (de) * | 2006-07-14 | 2008-01-17 | Bayer Healthcare Ag | Substituierte Indazole |
| JP5419706B2 (ja) | 2006-12-20 | 2014-02-19 | タケダ カリフォルニア インコーポレイテッド | グルコキナーゼアクチベーター |
| US9809545B2 (en) | 2013-03-27 | 2017-11-07 | Merck Sharp & Dohme Corp. | Factor XIa inhibitors |
| TWI633089B (zh) * | 2013-03-28 | 2018-08-21 | 拜耳製藥股份有限公司 | 經取代的酮基吡啶衍生物 |
| US9475809B2 (en) | 2013-07-23 | 2016-10-25 | Bayer Pharma Aktiengesellschaft | Substituted oxopyridine derivatives and use thereof as factor xia/plasma |
| WO2015063093A1 (fr) | 2013-10-30 | 2015-05-07 | Bayer Pharma Aktiengesellschaft | Dérivés d'oxopyridine substituée |
| WO2016046166A1 (fr) | 2014-09-24 | 2016-03-31 | Bayer Pharma Aktiengesellschaft | Dérivés d'oxopyridine substitués |
| WO2016046158A1 (fr) | 2014-09-24 | 2016-03-31 | Bayer Pharma Aktiengesellschaft | Dérivés d'oxopyridine substitués |
| JP6517925B2 (ja) | 2014-09-24 | 2019-05-22 | バイエル ファーマ アクチエンゲゼルシャフト | 置換されたオキソピリジン誘導体 |
| WO2016046156A1 (fr) | 2014-09-24 | 2016-03-31 | Bayer Pharma Aktiengesellschaft | Dérivés d'oxopyridine substitués |
| ES2716417T3 (es) | 2014-09-24 | 2019-06-12 | Bayer Pharma AG | Derivados de oxopiridina sustituidos con acción antiinflamatoria y antitrombótica |
| ES2712886T3 (es) * | 2014-09-24 | 2019-05-16 | Bayer Pharma AG | Derivados de piridobenzazepina y piridobenzazocina que inhiben el factor XIa |
| CA2979937A1 (fr) | 2015-03-19 | 2016-09-22 | Bayer Pharma Aktiengesellschaft | Derives d'oxopyridine comme inhibiteurs du facteur xia pour le traitement de la thrombose |
| JO3703B1 (ar) | 2015-07-09 | 2021-01-31 | Bayer Pharma AG | مشتقات أوكسوبيريدين مستبدلة |
| EP3344618A1 (fr) | 2015-09-04 | 2018-07-11 | Bayer Pharma Aktiengesellschaft | Dérivés d'oxopyridine substitués |
-
2019
- 2019-12-18 EA EA202191764A patent/EA202191764A1/ru unknown
- 2019-12-18 KR KR1020217022510A patent/KR20210106504A/ko not_active Ceased
- 2019-12-18 SG SG11202104384PA patent/SG11202104384PA/en unknown
- 2019-12-18 CR CR20210342A patent/CR20210342A/es unknown
- 2019-12-18 BR BR112021009435-0A patent/BR112021009435A2/pt not_active Application Discontinuation
- 2019-12-18 JP JP2021535063A patent/JP2022514303A/ja active Pending
- 2019-12-18 MX MX2021007508A patent/MX2021007508A/es unknown
- 2019-12-18 WO PCT/EP2019/085983 patent/WO2020127504A1/fr not_active Ceased
- 2019-12-18 PE PE2021000903A patent/PE20211790A1/es unknown
- 2019-12-18 EP EP19832641.5A patent/EP3898633A1/fr not_active Withdrawn
- 2019-12-18 AR ARP190103745A patent/AR117435A1/es unknown
- 2019-12-18 CA CA3124220A patent/CA3124220A1/fr active Pending
- 2019-12-18 CN CN201980091518.1A patent/CN113474348A/zh active Pending
- 2019-12-18 TW TW108146372A patent/TW202039510A/zh unknown
- 2019-12-18 MA MA054521A patent/MA54521A/fr unknown
- 2019-12-18 JO JOP/2021/0161A patent/JOP20210161A1/ar unknown
- 2019-12-18 AU AU2019407909A patent/AU2019407909B2/en not_active Ceased
-
2021
- 2021-06-14 IL IL283990A patent/IL283990A/en unknown
- 2021-06-16 CO CONC2021/0007908A patent/CO2021007908A2/es unknown
- 2021-06-16 EC ECSENADI202143895A patent/ECSP21043895A/es unknown
- 2021-06-17 CL CL2021001613A patent/CL2021001613A1/es unknown
- 2021-06-18 DO DO2021000128A patent/DOP2021000128A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MA54521A (fr) | 2022-03-30 |
| KR20210106504A (ko) | 2021-08-30 |
| JP2022514303A (ja) | 2022-02-10 |
| CO2021007908A2 (es) | 2021-07-19 |
| BR112021009435A2 (pt) | 2021-08-17 |
| CN113474348A (zh) | 2021-10-01 |
| PE20211790A1 (es) | 2021-09-09 |
| MX2021007508A (es) | 2021-08-05 |
| AR117435A1 (es) | 2021-08-04 |
| EP3898633A1 (fr) | 2021-10-27 |
| CR20210342A (es) | 2021-08-09 |
| DOP2021000128A (es) | 2021-09-30 |
| SG11202104384PA (en) | 2021-05-28 |
| CL2021001613A1 (es) | 2021-12-03 |
| AU2019407909B2 (en) | 2023-05-25 |
| AU2019407909A1 (en) | 2021-05-27 |
| CA3124220A1 (fr) | 2020-06-25 |
| JOP20210161A1 (ar) | 2023-01-30 |
| TW202039510A (zh) | 2020-11-01 |
| EA202191764A1 (ru) | 2021-10-22 |
| WO2020127504A1 (fr) | 2020-06-25 |
| IL283990A (en) | 2021-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2021007908A2 (es) | Derivados de oxopiridina sustituidos | |
| ECSP18001308A (es) | Derivados de oxopiridina sustituidos | |
| ECSP20072258A (es) | Derivados sustituidos de la carboxamida dihidropirazolo pirazina | |
| CR20150476A (es) | Oxopyridine derivados sustituidos y su uso en el tratamiento de trastornos cardiovasculares | |
| ECSP24024658A (es) | Derivados de s-alaninato sustituidos | |
| UY35344A (es) | Oestra-1,3,5(10),16-tetraeno-3-carboxamidas | |
| UY37671A (es) | N-ariletil-2-aminoquinolin-4-carboxamidas sustituidas y su uso | |
| UY37403A (es) | 1–arilnaftiridin–3–carboxamidas 7–sustituidas y su uso | |
| CL2021000930A1 (es) | Piridazinas novedosas | |
| CO2019011285A2 (es) | N-ariletil-2-arilquinolina -4-carboxamidas sustituidas y su uso | |
| NI201500168A (es) | Benzoxazoles sustituidos |